MAPT and Alzheimer disease: Research/diagnostics routine in AD includes a search for novel AD biomarkers (mutations, variants (e.g., ApoE)) or testing expression levels of known AD biomarkers (e.g., amyloid-β (Aβ), Tau, ApoE, Bin1, etc.)(Figure 1A,B).